DRW Securities’s Genmab GMAB Stock Holding History

DRW Securities’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,354	Closed	-$812K	–	1468
2025 Q4	$812K	Buy	26,354 +17,826	+209%	+$556K	0.02%	356
2025 Q3	$258K	Buy	+8,528	New	+$208K	﹤0.01%	933

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

DRW Securities's GMAB Position: Q1 2026 in Review

DRW Securities sold out of Genmab (GMAB) in Q1 2026, closing a stake of 26,354 shares — an estimated $812K sold.

DRW Securities first reported a position in GMAB in Q3 2025 and held it in 2 quarters. The position peaked at $812K in Q4 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

DRW Securities reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 26,354 Genmab shares in Q1 2026, an estimated $812K.
DRW Securities first reported a position in Genmab in Q3 2025 and held it in 2 quarters.
DRW Securities's Genmab position peaked at $812K in Q4 2025.
274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.